Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

Selection of CRO marks key milestone in advancing CS1 as [...]

Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

Ascidian Therapeutics has appointed Murray Abramson as chief development officer. [...]

CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

Cybin’s lead psychedelic-based candidate CYB003, designed as an adjunctive treatment [...]

Breye Therapeutics has announced the successful completion of its Phase [...]

A new white paper from contract research organisation Novotech has [...]

Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]